These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15334700)

  • 41. rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy.
    Chen GX; Zheng LH; Liu SY; He XH
    World J Gastroenterol; 2011 Oct; 17(38):4289-97. PubMed ID: 22090785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A phase II trial of epirubicin plus oxaliplatin and fluorouracil as first-line chemotherapy for advanced gastric cancer.
    Zhao JG; Xiong JP; Xiang XJ; Qiu F; Zhang L; Yu F
    Ai Zheng; 2009 Jan; 28(1):42-4. PubMed ID: 19448415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer.
    Yang L; Song Y; Zhou AP; Qin Q; Chi Y; Huang J; Wang JW
    Chin Med J (Engl); 2013; 126(18):3470-4. PubMed ID: 24034092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and pharmacokinetics study of oxaliplatin in colon cancer patients.
    Burz C; Berindan-Neagoe IB; Balacescu O; Tanaselia C; Ursu M; Gog A; Vlase L; Chintoanu M; Balacescu L; Leucuta SE; Irimie A; Cristea V
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):39-43. PubMed ID: 19337632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy.
    Shitara K; Chin K; Yoshikawa T; Katai H; Terashima M; Ito S; Hirao M; Yoshida K; Oki E; Sasako M; Emi Y; Tsujinaka T
    Gastric Cancer; 2017 Jan; 20(1):175-181. PubMed ID: 26626800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of traditional Tibetan drug Liu Tea on proliferation and chemotherapeutic sensitivity of drug-resistant human gastric cancer cell BGC823/5-FU].
    Cheng Y; Hasiqi MG; Qin XZ; Tang XY; Chen JN; Wang HY; Gao A
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):603-608. PubMed ID: 28871679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.
    Qin B; Tanaka R; Shibata Y; Arita S; Ariyama H; Kusaba H; Baba E; Harada M; Nakano S
    Anticancer Drugs; 2006 Apr; 17(4):445-53. PubMed ID: 16550003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trials.
    Huang J; Zhao Y; Xu Y; Zhu Y; Huang J; Liu Y; Zhao L; Li Z; Liu H; Wang QL; Qi X
    Oncotarget; 2016 Jun; 7(23):34824-31. PubMed ID: 27166187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
    Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide.
    Shao QS; Ye ZY; Ling ZQ; Ke JJ
    World J Gastroenterol; 2005 Jun; 11(22):3451-6. PubMed ID: 15948253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer.
    Satake H; Kondo M; Mizumoto M; Kotake T; Okita Y; Ogata T; Hatachi Y; Yasui H; Miki A; Imai Y; Ichikawa C; Murotani K; Kotaka M; Kato T; Kaihara S; Tsuji A
    Anticancer Res; 2017 Jul; 37(7):3703-3710. PubMed ID: 28668863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apoptosis of human gastric carcinoma cells induced by Euphorbia esula latex.
    Fu ZY; Han XD; Wang AH; Liu XB
    World J Gastroenterol; 2016 Apr; 22(13):3564-72. PubMed ID: 27053848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
    Liu P; Wang TS; You SH; Ge HM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol.
    Namikawa T; Maeda H; Kitagawa H; Oba K; Tsuji A; Yoshikawa T; Kobayashi M; Hanazaki K
    BMC Cancer; 2018 Feb; 18(1):186. PubMed ID: 29439671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Role and mechanism research on reversal of 5-fluorouracil resistance by epigallocatechin gallate in gastric cancer drug-resistance cells lines SGC-7901/5-FU].
    Tang H; Zhang X; Cui S; Wang J; Ruan Q; Huang Y; Yang D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1170-1175. PubMed ID: 27781257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Oxaliplatin plus capecitabine as a second line chemotherapy for patients with advanced gastric cancer].
    Qian J; Qin SK; Mei JF; Chen YX; Shao ZJ; He ZM
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):746-8. PubMed ID: 15733396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxaliplatin-based combination chemotherapy is still effective for the treatment of recurrent and platinum-resistant epithelial ovarian cancer: results from a single center.
    Zhang G; Li XP; Liu BJ; Wang JL; Wang SJ; Cui H; Wei LH
    Chin Med J (Engl); 2013 Dec; 126(23):4477-82. PubMed ID: 24286410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer.
    Kim KH; Park YS; Chang MH; Kim HS; Jun HJ; Uhm J; Yi SY; Lim DH; Ji SH; Park MJ; Lee J; Park SH; Park JO; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):347-53. PubMed ID: 19066894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study.
    Meulendijks D; de Groot JW; Los M; Boers JE; Beerepoot LV; Polee MB; Beeker A; Portielje JE; Goey SH; de Jong RS; Vanhoutvin SA; Kuiper M; Sikorska K; Pluim D; Beijnen JH; Schellens JH; Grootscholten C; Tesselaar ME; Cats A
    Cancer; 2016 May; 122(9):1434-43. PubMed ID: 26970343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiproliferative activity of rosamultic acid is associated with induction of apoptosis, cell cycle arrest, inhibition of cell migration and caspase activation in human gastric cancer (SGC-7901) cells.
    Sui CG; Meng FD; Li Y; Jiang YH
    Phytomedicine; 2015 Aug; 22(9):796-806. PubMed ID: 26220626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.